IL6 and cholangiocarcinoma: Moreover, the exposure of MSCs to these CCA-derived EVs can lead to the increased cytokine release of interleukin-6(IL6), which acts as a growth factor for this malignancy, as well as to the upregulation of STAT-3 phosphorylation, leading to increased CCA cell multiplication [81,82].